已收盘 11-20 16:00:00 美东时间
-0.280
-0.31%
Pennant, Iovance and BillionToOne are deeply oversold healthcare stocks, with RSI near 30, potentially offering opportunities despite recent setbacks.
11-20 19:12
Short seller Fuzzy Panda accuses BillionToOne of undisclosed Medicaid fraud, illegal kickbacks, and flawed tests in a scathing new report.
11-19 01:53
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
09-24 02:09
BillionToOne, Inc. (NASDAQ:BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the launch of UNITY's expanded Red Blood
02-10 01:32
BillionToOne shares traded higher premarket on possible continued momentum Tuesday before flattening at the beginning of the session.
01-13 22:43
Companies Reporting Before The Bell • TH International (NASDAQ:THCH) is likely ...
2025-12-09 19:11